De-Nol drug description: round double radius coated tablets of cream-white color, with inscription “gbr 152” on the one side and a square pattern with irregular sides and rounded angles from the other side. Odorless or with discreet odor of ammonia nitrogen.
Indications and usage:
– Active gastroduodenal ulcer, incl. this, associated with Helicobacter pylori;
– Chronic gastritis and duodenitis in the exacerbation phase, incl. those, associated with Helicobacter pylori;
– Irritable bowel syndrome with diarrhea;
– Functional dyspepsia not connected with GI tract structural disease.
– Hypersensitivity to drug constituents;
– Idiosyncrasy of the drug;
– Significant kidney impairment;
– Lactation period.
Pregnancy and lactation period:
De-nol should not be used during pregnancy. A woman who administrates De-nol shouldn’t breastfeed.
From the digestive system: possible nausea, vomiting, more frequent bowel movements, constipations. These symptoms are not dangerous to health and of temporary nature.
Allergic reactions: skin rash, skin itch.
In case of long-term treatment in high doses – encephalopathy, connected with Bismuthum accumulation in CNS.
Dosage and administration:
Per os, rinsing with small amount of water.
Adults and children over the age of 12 – 1 tablet 4 times a day 30 minutes before meals and before going to bed, or 2 tablets twice a day 30 minutes before meals.
Children from 8 to 12 years – 1 tablet twice a day 30 minutes before meals.
Children from 4 to 8 years – in a dose of 8 mg per kilo per day; daily dose should be divided for 2 administrations (30 minutes before meals).
Treatment duration – 4-8 weeks. During the next 8 weeks it is recommended to use the drug that contains Bismuthum.
For Helicobacter pylori eradication it is recommended to use De-nol in combination with other antibacterial medications with anti-helicobacter effect.